#Pulmonology in UAE

[jtsmedicalcentre]

JTS (Jumeirah Terrace Speciality) Medical Centre is Dubai’s #1 multi-specialty Medical Centre located in Jumeirah, offering comprehensive outpatient specialist medical & dental services.

The founding doctors are Dr. Suresh Puri, Dr. Abhay Dandawate, Dr. Marlon O. Pereira, and Dr. Mathews J. Alapatt. We have team of specialists and now offers and more than 30 specialists on board.

Watch & Subscribe us for more updates!

[zulekhahospitals-blog]

Innovative Treatments for Lung Diseases in the UAE

Pulmonology in the UAE has advanced significantly, offering comprehensive care for respiratory conditions. The country’s healthcare system prioritizes innovation and accessibility, ensuring residents receive top-notch pulmonary care. Pulmonologists in the UAE diagnose and treat a wide range of respiratory issues, including asthma, chronic obstructive pulmonary disease (COPD), lung infections, and sleep disorders.

Zulekha Hospital stands out as a leading institution in the UAE’s pulmonology landscape. With a team of highly qualified pulmonologists, the hospital provides state-of-the-art diagnostic and therapeutic services. Their pulmonary care includes advanced imaging, lung function tests, bronchoscopy, and pulmonary rehabilitation programs designed to improve patients' quality of life.

Zulekha Hospital’s commitment to integrating cutting-edge technology with personalized care ensures optimal treatment outcomes. They offer specialized clinics for asthma, COPD, and other chronic lung conditions, providing patients with tailored treatment plans. The hospital also emphasizes preventive care, conducting regular health screenings and educational programs to raise awareness about respiratory health.

Telehealth services at Zulekha Hospital further enhance accessibility, allowing patients to consult pulmonologists remotely, a crucial benefit during times like the COVID-19 pandemic. This holistic approach to pulmonology makes Zulekha Hospital a trusted destination for respiratory care in the UAE, reflecting the nation’s dedication to maintaining high standards in healthcare.

[pharmaconferenceandexpo]

"Discover the Power Within: Enroll in Our Life-Changing Workshop!" Become part of the Probulin Probiotics Community! We're thrilled to invite you to our upcoming workshop, where you'll delve into the incredible advantages of our probiotic offerings! Workshop Title: The Evolution in Probiotic Therapy Workshop Event Timing: May 21st, 2024 from 11:00 AM – 02:00 PM Workshop Event Address: Hyatt Regency Dubai Creek Heights, 20th Street, Dubai Healthcare City, Dubai 5668, UAE Visit Now: https://gastroenterology.universeconferences.com/the-evolution-in-probiotic-therapy/ #ProbulinProbiotics #ProbioticsWorkshop #InternalMedicine #HealthCare #Wellness #MedicalScience #Gastroenterology #Cardiology #Endocrinology #Pulmonology #Nephrology #Hematology #Rheumatology #Neurology

[blueweave]

UAE active pharmaceutical ingredients (API) market size at USD 1,264.75 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the UAE active pharmaceutical ingredients (API) market size to grow at a CAGR of 38.61% reaching a value of USD 8,967.75 million by 2029. The prevalence of chronic diseases is on the rise, and patients are increasingly demanding individualized treatment plans, which are two major growth reasons for the UAE active pharmaceutical ingredients (API) market. Additionally, it is projected that the development of novel drug delivery methods would have a substantial impact on the market expansion over the forecast period.

UAE Active Pharmaceutical Ingredients (API) Market – Overview

Active pharmaceutical ingredients (API) are chemically and physiologically active components of medications that have a direct impact on the treatment, mitigation, and prevention of illnesses. These are produced using both chemical and biological methods. Paracetamol in medications for pain treatment and atorvastatin in medications for decreasing cholesterol are two examples of active substances. Oncology, cardiology, CNS and neurology, orthopedics, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology are just a few of the medical specialties where APIs are used in high-quality medications.

Sample Request @ https://www.blueweaveconsulting.com/report/uae-active-pharmaceutical-ingredients-market/report-sample

[rohans18]

Middle East and Africa Plasma Fractionation Market Expected High Growth in Coming Years

Global Middle East and Africa Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others),  Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Middle East and Africa Plasma Fractionation and Traditional Middle East and Africa Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Middle East and Africa Plasma Fractionation marketing report. The report has a lot to offer to both established and new players in the Middle East and Africa Plasma Fractionation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Middle East and Africa Plasma Fractionation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the Middle East and Africa Plasma Fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-plasma-fractionation-market

With the help of credible Middle East and Africa Plasma Fractionation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Middle East and Africa Plasma Fractionation market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Middle East and Africa Plasma Fractionation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[prometricexamonline]

Hello Aspirant, Are you preparing for the Prometric Exam in the Gulf countries in the year 2023? If your answer is yes -we are here to help you for your succeed to get in to your life dream.

[medical-equipment-supplier-uae]

Maxvalue is an innovative solution provider in the healthcare field with expertise in Pulmonology equipments ,Cardiology and Sports Medicine.

[zulekhahospital]

Pulmonology in UAE

Are you suffer from any respiratory diseases? Searching for the best pulmonologist in UAE? No more worries. ZULEKHA HOSPITAL is the best hospital that provides the best treatments for respiratory diseases. Our department focuses on the diagnosis and treatment of chest and lungs. Dr. Hassan Hassan Eliwa Hassan Razein is a specialist in respiratory medicine of pulmonology in UAE.

[emedpharmatech]

#Telemedicine By Emedstore - One Solution For All Type Of Diseases Due to the pandemic, the world came to a standstill, and hospitals everywhere started being overwhelmed with the surge in infections and diseases. In such a situation, Telemedicine apps became a necessity to reduce infections and cure diseases, while allowing people to access remote healthcare. Here is how Telemedicine can be all in one solution for all types of diseases like Hematology, Neurology, Rheumatology, Cardiology, Endocrinology, Pulmonology, etc. #Telemedicine #doctor #patient #Nigeria #Kenya #SouthAfrica #Sudan #Zambia #UAE #Nepal #KSA #Ghana #Uganda #SriLanka #Philippines Request a free demo of Telemedicine: https://www.emedstore.in/telemedicine-app-development

[dailykhaleej]

Ramadan UAE: Quit smoking and also reduce coronavirus risk

Ramadan and the coronavirus pandemic an ideal time to give up, say specialists. Picture Credit score: Thinkstock

Abu Dhabi: At a time when the world is battling the coronavirus pandemic, docs are urging residents within the UAE to make use of the fasting month to surrender smoking

Identified for its adversarial well being results, smoking also will increase the risk of contracting the coronavirus, along with rising the severity of problems from COVID-19.

“Those who are fasting must naturally abstain from smoking for more than 12 hours every day. This reduces the level of nicotine in the blood. And since smoking as a habit is simply an addiction to nicotine, this drop in nicotine levels can get you halfway toward quitting the habit,” Dr Ayesha Khalid, household drugs guide on the Burjeel Hospital Abu Dhabi, advised DailyKhaleej.

The truth that Ramadan is steeped in spirituality ought to also assist worshippers hand over smoking, added Dr Sunil Vyas, pulmonology specialist at Aster Hospital Qusais.

Dr Sunil Vyas

“Any time should be a good time to give up the habit, but smokers may simply be more determined and motivated during this holy month,” Dr Vyas mentioned.

Coronavirus hyperlink 

Ever because the coronavirus outbreak started, the dangers to people who smoke have been in focus, particularly as a result of COVID-19 and inhaled smoke each goal the lungs.

Dr Mohammad Ajeaidi

“Smokers may be prone to severe COVID-19 infections, in part, because their lungs contain an abundance of entry points that the virus can exploit. COVID-19 infections begin at the ACE2 receptor. These receptors are nestled on the surface of cells throughout the body, including respiratory tracts. The coronavirus must plug into the ACE2 receptor in order to replicate and spread. And preliminary research suggests that lungs exposed to cigarette smoke accumulate abnormally larger numbers of ACE2 receptors, which may leave the organ more vulnerable to attracting the infection with more damage to lungs inflicted by the virus,” mentioned Dr Mohammad Ajeaidi, household drugs specialist at Medcare Medical Centre, Al Rashidiya.

The World Well being Organisation, in addition to the European Centres for Illness Management, have also highlighted different dangers to people who smoke, saying that the frequent contact between fingers and lips throughout smoking will increase the potential for the virus being transmitted.

Conflicting research

This recommendation from UAE docs is in direct contradiction to a different research in France that claims Nicotine may truly defend individuals from contracting the coronavirus. A prime Paris hospital examined 343 coronavirus sufferers together with 139 contaminated with the sickness with milder signs and discovered {that a} low variety of them smoked in comparison with smoking charges of round 35 per cent in France. The analysis echoed comparable findings within the New England Journal of Drugs final month that steered 12.6 per cent of 1,000 individuals contaminated in China had been people who smoke, a lot decrease than the 26 per cent nationwide price of people who smoke in China, in response to the World Well being Organisation. The speculation is that nicotine may adhere to cell receptors blocking the virus from getting into cells and spreading within the physique. French researchers now plan to trial nicotine patches on coronavirus sufferers to additional this research.

Extreme problems

As soon as the virus is contracted, people who smoke also face a better risk of extra critical diseases.

“Early research indicates that having a history of smoking may substantially increase the chance of adverse health outcomes for COVID-19 patients, including being admitted to intensive care, requiring mechanical ventilation and suffering severe health consequences. It is also associated with increased development of acute respiratory distress syndrome, a key complication for severe cases of COVID-19,” Dr Ajeaidi defined.

He added that people who smoke with COVID-19 who also produce other underlying power circumstances, like power obstructive pulmonary illness and heart problems are also extra vulnerable to critical problems and dying.

“The lungs of a non-smoker are just healthier, and better able to cope with the stresses to the lungs from COVID-19,” Dr Khalid mentioned.

And the dangers of smoking lengthen to all types of tobacco use, together with waterpipes (shisha) and pipe smoking, corresponding to midwakh. In reality, as a result of mouth items and hoses are shared throughout a shisha smoking session, with many individuals seated in shut proximity, the risk of transmitting the virus is heightened additional. The UAE subsequently introduced the closure of all shisha parlours in early March.

Quit now

Preserving these dangers in thoughts, docs are encouraging people who smoke to give up now, which is able to assist them capitalise on the nicotine withdrawals and elevated religious drives. In reality, physicians have lengthy touted Ramadan as a golden alternative to give up for many who quick.

Dr Khalid mentioned she has already come throughout plenty of people who find themselves making an attempt to kick the behavior in the meanwhile.

“One of my patients is using medication to reduce her dependence on nicotine, and another has gone cold turkey. The process is difficult, just like any other addiction, and non-smokers may not always be able to appreciate it. But there [are many resources available],” Dr Khalid suggested.

Dr Ajeaidi talked about the wrestle of quitting.

“[It is a] struggle, but with courage, determination, medical advice and professional help, you can achieve this goal of quitting. So find you reason to get motivated, [such as a desire] to protect yourself and your loved ones,” he mentioned.

Tricks to give up smoking

How one can give up smoking Picture Credit score: GettyImages/iStockphoto

Contemplate ‘going cold turkey’. Stopping smoking abruptly is a greater technique than chopping down steadily.

Make a promise, set a date and persist with it. Discover your purpose to get motivated for quitting smoking, perhaps to protected your family members and your self.

Contemplate nicotine substitute remedy. Once you cease smoking, nicotine withdrawal could provide you with complications, have an effect on your temper, or your power. There might be longing for “just one drag”. Nicotine substitute remedy can curb these urges. Nicotine gum, lozenges, and patches enhance your possibilities of success once you’re also in a quit-smoking program. It takes about two weeks to eliminate the craving.

Inform your pals, household, and different individuals you might be quitting smoking. They will encourage you to maintain going.

Use air fresheners to eliminate that acquainted scent. When you smoked in your automotive, clear it out too. You don’t need to see or odor something that reminds you of smoking.

Don’t begin new food regimen once you give up smoking; it could make issues tougher. Eat wholesome meals wealthy in fruits and greens.

You possibly can reward your self. Calculate the cash you’ll save after quitting smoking and reward your self by spending on one thing enjoyable.

Keep busy with non-smoker mates.

It could actually also assist to get a ‘quit smoking buddy’. As an example, a pair who smokes can give up the behavior collectively. This may assist take away temptations, and assist evaluate challenges and wins.

Supply: Dr Ayesha Khalid and Dr Mohammad Ajeaidi

from WordPress https://ift.tt/2zWDrIh via IFTTT

[jtsmedicalcentre]

Get excellence in respiratory care with Dubai's leading Pulmonologist!

Meet Dr. Suresh Puri, a renowned Pulmonologist known for expertise in respiratory medicine. With a passion for providing personalized care, Dr. Suresh Puri combines cutting-edge medical knowledge with a compassionate approach, ensuring a holistic and patient-centric experience. Visit us!

[zulekhahospitals-blog]

Stop searching for the best hospital for the best healthcare in Dubai! Here Zulekha Hospital is the perfect choice for you. We provide the best healthcare services for every health issues. Our highly qualified and specialized medical staff will provide the high quality care. Book an appointment now!

[pharmaconferenceandexpo]

"Discover the Power Within: Enroll in Our Life-Changing Workshop!" Become part of the Probulin Probiotics Community! We're thrilled to invite you to our upcoming workshop, where you'll delve into the incredible advantages of our probiotic offerings! Workshop Title: The Evolution in Probiotic Therapy Workshop Event Timing: May 21st, 2024 from 11:00 AM – 02:00 PM Workshop Event Address: Hyatt Regency Dubai Creek Heights, 20th Street, Dubai Healthcare City, Dubai 5668, UAE Visit Now: https://gastroenterology.universeconferences.com/the-evolution-in-probiotic-therapy/ #ProbulinProbiotics #ProbioticsWorkshop #InternalMedicine #HealthCare #Wellness #MedicalScience #Gastroenterology #Cardiology #Endocrinology #Pulmonology #Nephrology #Hematology #Rheumatology #Neurology

[technologyinfosec]

It's World Lung Cancer Day, stub that cigarette

Today on World Lung Cancer Day, UAE doctors are reiterating their plea: Smokers, stub out those cigarettes now. To this day, statistics haven't changed much. Smoking accounts for 80 to 90 per cent of lung cancer causes, according to the US-based Centers for Disease Control and Prevention. And a recent report by the World Health Organisation showed that tobacco kills more than seven million people each year - with six million deaths attributed to tobacco use and around 900,000 are non-smokers exposed to second-hand smoke. Doctors in the UAE stressed that lung cancer may also come from other forms of smoking, including midwakh (local tobacco that's inhaled through a small pipe), lifestyle factors and genetic disorders. "Globally, one in five deaths occur due to lung cancer. The strategies to prevent lung cancer should be targeted and lung screening programs should be implemented on a wide scale, boosted by intervention strategy such as smoking cessation programmes," Dr Sunil Vyas, pulmonology specialist at Aster Hospital, told Khaleej Times. More treatment options On a positive note, more options are now available for lung cancer treatment than ever before, said experts at Cleveland Clinic Abu Dhabi, but effective treatment still relies on early diagnosis through screening. Dr Redha Souilamas, chair of the thoracic surgery department at Cleveland Clinic Abu Dhabi (CCAD), said: "In cancer cases, time is very valuable. A patient needs to be treated without delay once a diagnosis is made. Increasingly, we are able to offer a broad spectrum of oncology treatments that help to address the immediate issue of the cancer and help patients on their path to recovery." "The philosophy behind screening for lung cancer is to reduce the number of people who die from the disease by detecting it early on, when it is easier to treat," added Dr Jeffrey Chapman, chair of the Respiratory Institute at CCAD, said that ideally, screening must be done before the disease has advanced enough to cause symptoms. "This is where patient awareness is important, because many people wait until they have symptoms, when the cancer has already developed," he explained. But doctors say prevention will always be better than cure. "Lung cancer is preventable, all you need is will power to give up smoking! There are some other causes of lung cancer too such as over exposure to industrial pollutants, asbestos and silicon so precaution should be taken to avoid these factors," said Dr C S Vasantha Kumar, specialist internal medicine, Panacea Medical and Wellness Centre Read the full article

[rohans18]

Asia- Pacific Plasma Fractionation Market Expected High Growth in Coming Years

Global Asia- Pacific Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others),  Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Asia- Pacific Plasma Fractionation and Traditional Asia- Pacific Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Asia- Pacific Plasma Fractionation marketing report. The report has a lot to offer to both established and new players in the Asia- Pacific Plasma Fractionation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Asia- Pacific Plasma Fractionation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the Asia- Pacific Plasma Fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/asia-pacific-plasma-fractionation-market

With the help of credible Asia- Pacific Plasma Fractionation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Asia- Pacific Plasma Fractionation market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Asia- Pacific Plasma Fractionation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[jayashreeblr-blog]

Middle-East Active Pharmaceutical Ingredients Market is expected to reach USD 19.5 Billion by 2026 from USD 11.1 Billion in 2016 at a CAGR of 5.9% (Detailed analysis of the market CAGR is provided in the report).

 An active ingredient is that constituent of a pharmaceutical drug that is organically active. The active ingredient was traditionally known as pharmacon meaning magical substance within drugs. Active pharmaceutical ingredients (API) and bulk active are both synonymously used for representing active ingredients. The content of API is dependent on the manufacturers and usually differs from one brand to another. There are certain products that may contain more than one active ingredient. A drug consists of API which is the main medication and the excipient which holds the API together and carries it to the system for providing medication. The material in which API is suspended are chemically inert by nature and does not directly participate in the API. Patients are somewhat more aware of the API and have lesser or no knowledge about the excipient component. Therefore, drugs are commonly selected based on the active ingredients rather than the excipient.

Active pharmaceutical ingredient market for Middle-east is distributed into manufacturer type, synthesis type, drug type, therapeutic area, and geography. The synthesis type segment of the market is segmented into biotech and synthetic. The biotech segment was one of the fastest growing with factors such as high R&D for biosimilar drugs, and a shift in focus of traditional manufacturers towards biological drugs boosting overall market growth. Branded drugs, generic drugs and over-the-counter (OTC) drugs are the three kinds of drug type segment in active pharmaceutical ingredients market. The rise in drug prices along with higher investments in different R&D activities have made branded drugs the largest segment of active pharmaceutical ingredients market. Captive and merchant manufacturers are the two key types for the manufacturer type segment in the market. The merchant manufacturers will likely form one of the fastest growing segment. The rise in outsourcing of API/ drug molecule formulation has been one of the major factors to escalate growth of merchant manufacturers. Outsourcing by drug manufacturers eliminates the need for heavy investment in the manufacturing process playing another major role in the growth of merchant manufacturers within active pharmaceutical ingredients market.

The UAE and Saudi Arabia are a few major countries that have contributed to the growth of active pharmaceutical ingredients market in Middle-east. The Middle-east region has seen one of the highest growth owing to increased investments in R&D activities. Presence of many pharmaceutical companies owning their research facilities in Middle-east has been another major factor that has boosted the growth of active pharmaceutical ingredients market.

Key Highlights:

• Middle-East Active Pharmaceutical Ingredients market size analysis and forecast

• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Middle-East Active Pharmaceutical Ingredients Market

• Active Pharmaceutical Ingredients market segmentation on the basis of synthesis type, drug type, manufacturer type, therapeutic area, and geography.

• Active Pharmaceutical Ingredients market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study

• Active Pharmaceutical Ingredients market analysis and forecast for major countries have been provided.

• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies

• Competitive landscape of the key players operating in the Active Pharmaceutical Ingredients market including competitive developments, investments, and strategic expansion

Years that have been considered for the study are as follows:

• Base Year – 2016

• Estimated Year – 2017

• Forecast Period – 2017 to 2026

For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered.

Research Methodology:

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for Middle-East Active Pharmaceutical Ingredients market.

Some of the key players of the Middle-East Active Pharmaceutical Ingredients market include:

• SGS

• Albemarle Corporation

• Julphar

• BASF

• Merck & Co., Inc.

• Sun Pharmaceuticals

• Dr. Reddy’s Laboratories

• Aurobindo Pharma

• Sandoz

• Abbvie

Key Target Audience:

• Healthcare companies

• Corporate healthcare entities

• Government agencies

• Market research and consulting firms

• Venture capitalists

• Technical Students

For more information visit:

https://www.maximizemarketresearch.com/market-report/active-pharmaceutical-ingredients-market-middle-east/2237/

Scope of the Active Pharmaceutical Ingredients Market Report:

The research report segments Middle-East Active Pharmaceutical Ingredients market based on synthesis type, drug type, manufacturer type, therapeutic area and geography.

Active Pharmaceutical Ingredients Market, By Synthesis Type

• Biotech

• Monoclonal Antibodies

• Recombinant Proteins

• Vaccines

• Synthetic

Active Pharmaceutical Ingredients Market, By Drug Type

• Branded Drugs

• Generic Drugs

• Over-the-counter (OTC) Drugs

Active Pharmaceutical Ingredients Market, By Manufacturer Type

• Captive Manufacturers

• Merchant Manufacturers

Active Pharmaceutical Ingredients Market, By Therapeutic Area

• Cardiology

• Pulmonology

• Oncology

• Neurology

• Ophthalmology

• Orthopedics

• Others

Active Pharmaceutical Ingredients Market, By Geography:

• Middle-East

• GCC Countries

• Israel

• Others

Geographic Analysis:

• Breakdown of GCC Countries Active Pharmaceutical Ingredients market

• Breakdown of Israel Active Pharmaceutical Ingredients market

• Breakdown of Others Active Pharmaceutical Ingredients market

This Report Is Submitted By Maximize Market Research

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

 Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Maharashtra 411051, India.

Contact:+919607065656